- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: VASH1
Gene name: vasohibin 1
HGNC ID: 19964
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | ANXA2 | 1 hits |
| 2 | CCRK | 1 hits |
| 3 | VEGFA | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 19057892 | Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. |
| 2 | 20659423 | Here, we analyzed how the expression of the two active anti-angiogenic VASH-1 isoforms p36 and p42 was altered during physiological and pathological muscle angio-adaptation. |
| 3 | 20659423 | Interestingly, expression patterns for p36 and p42 were different between plantaris and heart muscles. |
| 4 | 20659423 | Both p36 and p42 isoforms were increased, a signal in favor of some vessel destabilization and regression. |
| 5 | 20659423 | In conclusion, our results bring evidence that endogenous VASH-1 isoforms p36 and p42 are key actors of physiological and pathological muscle angio-adaptation. |
| 6 | 20659423 | Here, we analyzed how the expression of the two active anti-angiogenic VASH-1 isoforms p36 and p42 was altered during physiological and pathological muscle angio-adaptation. |
| 7 | 20659423 | Interestingly, expression patterns for p36 and p42 were different between plantaris and heart muscles. |
| 8 | 20659423 | Both p36 and p42 isoforms were increased, a signal in favor of some vessel destabilization and regression. |
| 9 | 20659423 | In conclusion, our results bring evidence that endogenous VASH-1 isoforms p36 and p42 are key actors of physiological and pathological muscle angio-adaptation. |
| 10 | 21228103 | An increase in the renal levels of VEGF-A, VEGFR-2, transforming growth factor (TGF)-β1, and monocyte chemoattractant protein-1 in diabetic animals was significantly suppressed by AdhVASH-1 (immunoblotting). |
| 11 | 21228103 | AdhVASH-1 treatment significantly recovered the loss and altered the distribution patterns of nephrin and zonula occludens (ZO)-1 and suppressed the increase in the number of fibroblast-specific protein-1 (FSP-1(+)) and desmin(+) podocytes in diabetic mice. |
| 12 | 21228103 | In vitro, recombinant human VASH-1 (rhVASH-1) dose dependently suppressed the upregulation of VEGF induced by high ambient glucose (25 mM) in cultured mouse podocytes. |
| 13 | 21228103 | In addition, rhVASH-1 significantly recovered the mRNA levels of nephrin and the protein levels of ZO-1 and P-cadherin and suppressed the increase in protein levels of desmin, FSP-1, Snail, and Slug in podocytes under high-glucose condition. |